Literature DB >> 9136520

Acute Q fever as a cause of acute febrile illness of unknown origin in Taiwan: report of seven cases.

W C Ko1, J W Liu, Y C Chuang.   

Abstract

Acute Q fever, caused by Coxiella burnetii has been well documented in Western countries, but only recently identified in Taiwan. Seven cases diagnosed by indirect fluorescent antibodies to phase II antigens of C. burnetii are reported. The patients were all men and a history of animal contact could be traced in most cases. Clinical manifestations were high fever, chills, relative bradycardia and elevated serum aminotransferases. Therapy with tetracycline or clarithromycin resulted in defervescence within 96 hours. Combining the knowledge on the prevalence of Q fever in Taiwan, the typical exposure history and clinical features in acute Q fever infection, primary care physicians may be able to avoid invasive but futile diagnostic intervention for patients with prolonged febrile illness. Prior to results from serologic testing, empiric therapy with tetracycline or its analogs may be considered for patients with typical clinical manifestations.

Entities:  

Mesh:

Year:  1997        PMID: 9136520

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  3 in total

1.  Newer macrolides as empiric treatment for acute Q fever infection.

Authors:  A Gikas; D P Kofteridis; A Manios; J Pediaditis; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Seroprevalence of Coxiella burnetii in patients presenting with acute febrile illness at Marigat District Hospital, Baringo County, Kenya.

Authors:  Allan P Lemtudo; Beth K Mutai; Lizzy Mwamburi; John N Waitumbi
Journal:  Vet Med Sci       Date:  2021-05-06

3.  Fever of unknown origin and Q-fever: a case series in a Bulgarian hospital.

Authors:  Magdalena Baymakova; Georgi T Popov; Radina Andonova; Valentina Kovaleva; Ivan Dikov; Kamen Plochev
Journal:  Caspian J Intern Med       Date:  2019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.